Copy
June 2021 
Enhanced Quality in Primary Care for Elders
with Diabetes and Dementia 
(EQUIPED-ADRD)
Deprescribing Considerations:

What are the considerations for our older patients?
  • Medications and therapies can have substantial benefits; there are times when discontinuing a medication might be harmful
  • Some medications and treatments can have unwanted side effects, may cause patients and their caregivers burden and can be expensive
  • As you know, polypharmacy is common amongst older adults; deprescribing is one strategy to address this
  • Below we put together a list of tools and resources for deprescribing. 
Helpful Tools for Deprescribing: 
US Deprescribing Research Network
Why do you think medication deprescribing is so hard? 
"Part of it is the technical aspect, there is a lot more guidance on how to start medications than how to stop them, how to do tapering effectively, but a big part of it is the psychology. When we add a medication, there's a perception that we are doing something positive to help the patient, but when we stop a medication there are many more barriers..." -  Mike Steinman, MD 
 
Uncovering Medication Related Problems: A Podcast with Mike Steinman and Francesca Nicosia

Dr. Steinman is the co-Principal Investigator of the US Deprescribing Research Network, an NIH-funded national research network for research on deprescribing medications in older adults.
GeriPal - A Geriatrics and Palliative Care Podcast. “Uncovering Medication Related Problems: A Podcast with Mike Steinman and Francesca Nicosia.” SoundCloud, soundcloud.com/geripal/geripal-medication-errors_ep111. Accessed May 28, 2021. 
Deprescribing.org
Choosing Wisely
AGS 2019 Updated Beers Criteria
NYU Guidelines for Diabetes with Alzheimer's Disease and Related Dementia NYU Guidelines for Diabetes with Alzheimer's Disease and Related Dementia
Literature 

Joshua Chodosh, MD, MSHS, FACP
Director, Division of Geriatrics and Palliative Care
Director, Freedman Center on Aging, Technology and Cognitive Health (CATCH)
NYU CDC BOLD Public Health Center of Excellence for Early Detection of Dementia, co-Lead
NYU Alzheimer’s Disease Center ORE Core Leader
Professor of Medicine and Population Health
EQUIPED-ADRD
An enhanced quality improvement initiative (QI) to improve ambulatory care for older patients with Diabetes Mellitus and Alzheimer’s Disease and Related Dementias (DM-ADRD) and their caregivers.
 
LEADS:
Joshua Chodosh, MD, MSHS, FACP
Rosie Ferris, MPH
Project Manager 
(646) 501-0601
Rosie.Ferris@nyulangone.org

Division of Geriatric Medicine and Palliative Care
Department of Medicine, NYU School of Medicine






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
NYU Langone Health · 550 First Avenue · New York, NY 10016 · USA